# BCBSMI Hospital Analysis Addendum

*Generated: September 08, 2025*
*Analysis Type: Hospital-Level Pharmaceutical Influence Assessment*

---

## Executive Summary

### Critical Findings for Payor Consideration

Analysis of Michigan hospital systems reveals concentrated pharmaceutical influence patterns that warrant immediate attention from a cost containment perspective. Among 1422 analyzed facilities serving BCBSMI members, we identified **0 critical-risk** and **7 high-risk hospitals** based on payment concentration, prescribing patterns, and provider coverage.

Key metrics demanding payor attention:
- **$2,173,390,870** in pharmaceutical payments to providers at Michigan hospitals
- **$75,508,819,956** in high-cost drug prescriptions from these facilities
- **62.6%** average payment penetration across hospital systems
- **220,638** BCBSMI-affiliated providers included in analysis

The concentration of pharmaceutical relationships within specific hospital systems creates potential cost drivers that directly impact BCBSMI's medical loss ratio and member premiums.


## Hospital Risk Ranking

### Methodology
Hospitals are scored on a 100-point scale incorporating:
- **Payment Intensity (30 points)**: Average payment per provider
- **Payment Penetration (30 points)**: Percentage of providers receiving payments
- **Prescription Volume (20 points)**: Total cost of high-risk drug prescriptions
- **Provider Concentration (20 points)**: BCBSMI provider coverage at facility

### Top 10 High-Risk Hospitals for Investigation

| Rank | Hospital | City | Risk Score | Category | Total Payments | BCBSMI Providers | Payment Penetration |
|------|----------|------|------------|----------|----------------|------------------|---------------------|
| 1 | Grass Lake Surgery Center | Grass Lake | 73.4 | High | $3,533,872 | 12 | 100.0% |
| 2 | Pro Care Health Solutions | Bingham Farms | 64.2 | High | $3,964,689 | 23 | 82.6% |
| 3 | Corewell Health William Beaumont University Hospital (AKA Beaumont Hospital - Royal Oak) | Royal Oak | 64.1 | High | $87,286,786 | 6703 | 82.6% |
| 4 | Optalis Health & Rehabilitation of Ann Arbor (FKA ProMedica Skilled Nursing and Rehabilitation - Ann Arbor) | Ann Arbor | 63.2 | High | $4,519,556 | 23 | 60.9% |
| 5 | Heart & Vascular Institute | Dearborn | 61.1 | High | $2,220,642 | 17 | 100.0% |
| 6 | Corewell Health Beaumont Troy Hospital (AKA Beaumont Hospital - Troy) | Troy | 60.5 | High | $71,184,478 | 4545 | 84.6% |
| 7 | Corewell Health East (FKA Beaumont Health System) | Royal Oak | 60.3 | High | $61,769,769 | 3957 | 85.4% |
| 8 | Town Center ASC | Troy | 59.0 | Medium | $5,943,111 | 36 | 94.4% |
| 9 | Corewell Health Physicians (FKA Beaumont Health Physicians) | Holland | 58.9 | Medium | $67,910,829 | 5458 | 81.5% |
| 10 | Fox Run Assisted Living | Novi | 58.3 | Medium | $6,079,502 | 50 | 80.0% |


## Payment Concentration Analysis

### Hospitals with Highest Pharmaceutical Payment Volume

These facilities represent the greatest concentration of pharmaceutical industry financial relationships:


#### Corewell Health William Beaumont University Hospital (AKA Beaumont Hospital - Royal Oak), Royal Oak
- **Total Payments**: $87,286,786
- **Providers with Payments**: 5539 of 6703 (82.6%)
- **Average Payment per Provider**: $15,759
- **Maximum Single Provider Payment**: $4,882,593
- **Total Transactions**: 504,883
- **Average Manufacturers per Provider**: 11.6

#### Corewell Health Beaumont Troy Hospital (AKA Beaumont Hospital - Troy), Troy
- **Total Payments**: $71,184,478
- **Providers with Payments**: 3844 of 4545 (84.6%)
- **Average Payment per Provider**: $18,518
- **Maximum Single Provider Payment**: $4,882,593
- **Total Transactions**: 381,495
- **Average Manufacturers per Provider**: 12.5

#### Corewell Health Physicians (FKA Beaumont Health Physicians), Holland
- **Total Payments**: $67,910,829
- **Providers with Payments**: 4448 of 5458 (81.5%)
- **Average Payment per Provider**: $15,268
- **Maximum Single Provider Payment**: $4,882,593
- **Total Transactions**: 408,238
- **Average Manufacturers per Provider**: 11.6

#### Corewell Health East (FKA Beaumont Health System), Royal Oak
- **Total Payments**: $61,769,769
- **Providers with Payments**: 3380 of 3957 (85.4%)
- **Average Payment per Provider**: $18,275
- **Maximum Single Provider Payment**: $4,882,593
- **Total Transactions**: 369,197
- **Average Manufacturers per Provider**: 13.7

#### University Hospital, Ann Arbor
- **Total Payments**: $60,114,685
- **Providers with Payments**: 3223 of 5624 (57.3%)
- **Average Payment per Provider**: $18,652
- **Maximum Single Provider Payment**: $6,418,017
- **Total Transactions**: 203,151
- **Average Manufacturers per Provider**: 5.2


## High-Cost Prescription Patterns

### Hospitals Driving Expensive Drug Utilization

Analysis of prescribing patterns for high-cost medications (ELIQUIS, HUMIRA, OZEMPIC, TRULICITY, JARDIANCE, XARELTO, ENBREL, STELARA) reveals concentrated utilization patterns:

| Hospital | City | Total Rx Cost | Total Prescriptions | Top Drugs |
|----------|------|---------------|---------------------|-----------|
| Corewell Health William Beaumont University Hospital (AKA Beaumont Hospital - Royal Oak) | Royal Oak | $1,981,798,368 | 2,319,465 | ELIQUIS: $437.3M, TRULICITY: $412M, OZEMPIC: $351.7M |
| Corewell Health Beaumont Troy Hospital (AKA Beaumont Hospital - Troy) | Troy | $1,499,383,418 | 1,756,450 | ELIQUIS: $358.9M, TRULICITY: $290.8M, OZEMPIC: $267.1M |
| Corewell Health Physicians (FKA Beaumont Health Physicians) | Holland | $1,488,381,887 | 1,805,765 | ELIQUIS: $381.6M, TRULICITY: $277.7M, OZEMPIC: $255.4M |
| University Hospital | Ann Arbor | $1,471,289,391 | 1,524,976 | TRULICITY: $297.9M, ELIQUIS: $270.3M, OZEMPIC: $257.2M |
| Corewell Health East (FKA Beaumont Health System) | Royal Oak | $1,399,155,388 | 1,684,233 | ELIQUIS: $364M, TRULICITY: $261.8M, OZEMPIC: $235.5M |
| Corewell Health Butterworth Hospital (FKA Spectrum Health Butterworth Hospital) | Grand Rapids | $1,368,406,876 | 1,558,217 | TRULICITY: $337.9M, ELIQUIS: $320.4M, STELARA: $205.5M |
| Corewell Health Dearborn Hospital (AKA Beaumont Hospital - Dearborn) | Dearborn | $1,334,660,625 | 1,591,720 | TRULICITY: $297.6M, ELIQUIS: $273.6M, OZEMPIC: $247.5M |
| Henry Ford Jackson Hospital (FKA Henry Ford Allegiance Health) | Jackson | $1,333,273,030 | 1,484,587 | ELIQUIS: $328.6M, OZEMPIC: $236M, TRULICITY: $212M |
| Corewell Health Beaumont Grosse Pointe Hospital (AKA Beaumont Hospital - Grosse Pointe) | Grosse Pointe | $1,112,946,232 | 1,284,795 | ELIQUIS: $242.9M, TRULICITY: $242.6M, OZEMPIC: $212.3M |
| Elara Caring Home Health - Jackson (FKA Great Lakes Caring Home Health - Jackson) | Jackson | $1,110,988,324 | 1,424,160 | TRULICITY: $321.7M, OZEMPIC: $243.8M, ELIQUIS: $225.2M |


## Detailed Hospital Profiles

### In-Depth Analysis of Highest Risk Facilities


---

### 1. Grass Lake Surgery Center
**Location**: Grass Lake, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 73.4/100

#### Provider Network
- **Total Providers**: 15
- **BCBSMI Providers**: 12 (80.0% coverage)
- **Providers with Payments**: 12 (100.0% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $3,533,872
- **Average Payment per Provider**: $294,489
- **Maximum Provider Payment**: $3,035,310
- **Total Transactions**: 1,113

#### Prescription Impact
- **Total Prescription Cost**: $0
- **Total Prescriptions**: 0
- **Key Drugs**: 0

#### Risk Assessment
- Payment Intensity Score: 27.4/30
- Payment Penetration Score: 30.0/30
- Prescription Volume Score: 0.0/20
- Provider Concentration Score: 16.0/20

---

### 2. Pro Care Health Solutions
**Location**: Bingham Farms, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 64.2/100

#### Provider Network
- **Total Providers**: 23
- **BCBSMI Providers**: 23 (100.0% coverage)
- **Providers with Payments**: 19 (82.6% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $3,964,689
- **Average Payment per Provider**: $208,668
- **Maximum Provider Payment**: $3,904,492
- **Total Transactions**: 2,027

#### Prescription Impact
- **Total Prescription Cost**: $6,192,438
- **Total Prescriptions**: 9,160
- **Key Drugs**: ELIQUIS: $2.2M, OZEMPIC: $1.3M, JARDIANCE: $1.2M

#### Risk Assessment
- Payment Intensity Score: 19.4/30
- Payment Penetration Score: 24.8/30
- Prescription Volume Score: 0.1/20
- Provider Concentration Score: 20.0/20

---

### 3. Corewell Health William Beaumont University Hospital (AKA Beaumont Hospital - Royal Oak)
**Location**: Royal Oak, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 64.1/100

#### Provider Network
- **Total Providers**: 7497
- **BCBSMI Providers**: 6703 (89.4% coverage)
- **Providers with Payments**: 5539 (82.6% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $87,286,786
- **Average Payment per Provider**: $15,759
- **Maximum Provider Payment**: $4,882,593
- **Total Transactions**: 504,883

#### Prescription Impact
- **Total Prescription Cost**: $1,981,798,368
- **Total Prescriptions**: 2,319,465
- **Key Drugs**: ELIQUIS: $437.3M, TRULICITY: $412M, OZEMPIC: $351.7M

#### Risk Assessment
- Payment Intensity Score: 1.5/30
- Payment Penetration Score: 24.8/30
- Prescription Volume Score: 20.0/20
- Provider Concentration Score: 17.9/20

---

### 4. Optalis Health & Rehabilitation of Ann Arbor (FKA ProMedica Skilled Nursing and Rehabilitation - Ann Arbor)
**Location**: Ann Arbor, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 63.2/100

#### Provider Network
- **Total Providers**: 31
- **BCBSMI Providers**: 23 (74.2% coverage)
- **Providers with Payments**: 14 (60.9% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $4,519,556
- **Average Payment per Provider**: $322,825
- **Maximum Provider Payment**: $4,442,861
- **Total Transactions**: 1,455

#### Prescription Impact
- **Total Prescription Cost**: $5,769,484
- **Total Prescriptions**: 8,160
- **Key Drugs**: ELIQUIS: $2.9M, XARELTO: $1.4M, TRULICITY: $0.6M

#### Risk Assessment
- Payment Intensity Score: 30.0/30
- Payment Penetration Score: 18.3/30
- Prescription Volume Score: 0.1/20
- Provider Concentration Score: 14.8/20

---

### 5. Heart & Vascular Institute
**Location**: Dearborn, Michigan  
**Risk Category**: High  
**Composite Risk Score**: 61.1/100

#### Provider Network
- **Total Providers**: 18
- **BCBSMI Providers**: 17 (94.4% coverage)
- **Providers with Payments**: 17 (100.0% penetration)

#### Financial Relationships
- **Total Pharmaceutical Payments**: $2,220,642
- **Average Payment per Provider**: $130,626
- **Maximum Provider Payment**: $1,444,413
- **Total Transactions**: 4,982

#### Prescription Impact
- **Total Prescription Cost**: $11,054,196
- **Total Prescriptions**: 16,687
- **Key Drugs**: ELIQUIS: $4.1M, XARELTO: $3.2M, OZEMPIC: $1.7M

#### Risk Assessment
- Payment Intensity Score: 12.1/30
- Payment Penetration Score: 30.0/30
- Prescription Volume Score: 0.1/20
- Provider Concentration Score: 18.9/20


## Actionable Recommendations for BCBSMI

### Immediate Actions (0-30 days)

1. **Enhanced Prior Authorization Review**
   - Implement stricter prior authorization requirements for high-cost medications at the 0 critical-risk hospitals
   - Focus on: HUMIRA, OZEMPIC, TRULICITY, and other identified high-correlation drugs
   - Expected impact: 10-15% reduction in unnecessary prescriptions

2. **Provider Engagement Program**
   - Initiate dialogue with medical directors at top 5 highest-risk facilities
   - Share comparative prescribing data and cost implications
   - Develop facility-specific cost reduction targets

3. **Network Evaluation**
   - Review network contracts with critical-risk hospitals
   - Consider performance-based incentives tied to generic utilization rates
   - Evaluate narrow network options excluding highest-cost facilities

### Short-term Initiatives (30-90 days)

4. **Formulary Management**
   - Develop hospital-specific formulary restrictions based on payment patterns
   - Implement step therapy requirements for providers with high payment concentrations
   - Create preferred drug lists emphasizing lower-cost therapeutic alternatives

5. **Provider Education Campaign**
   - Launch targeted education on cost-effective prescribing
   - Distribute comparative effectiveness data for high-cost vs. alternative medications
   - Highlight potential conflicts of interest to promote awareness

6. **Claims Analytics Enhancement**
   - Implement real-time monitoring of prescription patterns from high-risk facilities
   - Create alerts for unusual prescribing spikes or pattern changes
   - Develop predictive models to identify emerging cost drivers

### Long-term Strategies (90+ days)

7. **Value-Based Contracting**
   - Negotiate outcome-based agreements with pharmaceutical manufacturers
   - Develop shared savings programs with hospitals showing improvement
   - Create quality metrics that balance clinical outcomes with cost efficiency

8. **Transparency Initiative**
   - Publish hospital-level cost and quality scorecards for members
   - Create provider-specific prescribing profiles accessible to patients
   - Advocate for stronger sunshine law requirements at state level

9. **Alternative Payment Models**
   - Pilot bundled payment programs that include medication costs
   - Develop capitated models that incentivize cost-effective prescribing
   - Create gain-sharing arrangements for hospitals that reduce pharmaceutical costs

### Expected Impact

Implementation of these recommendations could yield:
- **15-20% reduction** in high-cost drug utilization at targeted facilities
- **$50-75 million** in annual savings based on current prescription volumes
- **Improved member satisfaction** through reduced out-of-pocket costs
- **Enhanced network quality** through evidence-based prescribing practices

### Monitoring and Evaluation

Establish quarterly reviews to track:
- Changes in payment patterns at monitored hospitals
- Prescription cost trends by facility and provider
- Prior authorization approval/denial rates
- Member complaints and appeals related to formulary changes
- Overall medical loss ratio impact


## Methodology and Data Sources

### Data Sources
- **Provider Affiliations**: PHYSICIANS_FACILITY_AFFILIATIONS_CURRENT_optimized
- **Payment Data**: op_general_all_aggregate_static_optimized (2020-2024)
- **Prescription Data**: PHYSICIAN_RX_2020_2024_optimized
- **Provider List**: BCBSMI provider network (49,576 NPIs)

### Analysis Period
- Payment data: 2020-2024 (5 years)
- Prescription data: 2020-2024 (5 years)
- Analysis date: Current

### Risk Scoring Methodology
Composite risk scores calculated using weighted factors:
1. **Payment Intensity (30%)**: Average payment amount per provider receiving payments
2. **Payment Penetration (30%)**: Percentage of affiliated providers receiving payments
3. **Prescription Volume (20%)**: Total cost of high-risk drug prescriptions
4. **Provider Concentration (20%)**: Percentage of hospital providers in BCBSMI network

### Inclusion Criteria
- Michigan hospitals with â‰¥10 affiliated providers
- Facilities with BCBSMI provider coverage
- Prescription volume >$1 million for targeted drugs

### Statistical Approach
- Aggregation at hospital-facility level
- Risk percentile ranking across all analyzed facilities
- Categorical risk assignment based on composite scores

### Limitations
- Analysis limited to Medicare Part D prescription data
- Payment data reflects reported Open Payments transactions only
- Hospital affiliations based on primary facility designation
- Temporal associations do not establish causation


---

## Report Metadata

- **Generated**: September 08, 2025 at 04:15 PM
- **Report Type**: Hospital Analysis Addendum
- **Client**: Blue Cross Blue Shield Michigan
- **Classification**: Confidential - Internal Use Only
- **Prepared by**: Conflixis Data Analytics Team

*This addendum supplements the main BCBSMI investigative report (bcbsmi_investigative_report_20250908_140110.md)*
